Clinical Trial Update: Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intraocular pressure reduction by Rhopressa and Lumigan in normal tension glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Normal Tension Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)
• RHOPRESSA (NETARSUDIL)

Snippet

Sponsor: Salus University | Conditions: Normal Tension Glaucoma | Phase 4 | Status: UNKNOWN